Clinical Trials on Nocturnal Hypokinesia

Total 430 results

Chulalongkorn University
Abbott

Unknown

Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors

Nocturnal Hypokinesia
National Taiwan University Hospital

Unknown

The Effect of LSVT LOUD for Mandarin-speaking Individuals With Hypokinetic Dysarthria Due to Parkinson's Disease

Hypokinetic Dysathria

Taiwan
Sleep Medicine Centre Kempenhaeghe

Terminated

Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

Nocturnal Hypokinesia | Parkinsons's Disease | Rotigotine

Netherlands
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Nocturia Due to Nocturnal Polyuria

Japan
Ferring Pharmaceuticals

Completed

Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)

Nocturia Associated With Nocturnal Polyuria

Germany
Rabin Medical Center

Unknown

Treatment of Enuresis Nocturna by Circular Muscle Exercise (Paula Method)

Monosymptomatic Enuresis Nocturna

Israel
Ferring Pharmaceuticals

Completed

A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US

Nocturnal Polyuria

United States
Mansoura University

Completed

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

Nocturnal Incontinence
Ferring Pharmaceuticals

Completed

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia) (NOC01)

Nocturia Due to Nocturnal Polyuria

Japan
Duramed Research

Completed

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Nocturnal Vasomotor Symptoms

United States
Mansoura University

Recruiting

Adding Desmopressin to Tamsulosin for Treatment of BPH

Nocturnal Polyurea in Patients With BPH

Egypt
The University of Hong Kong
The Hong Kong Jockey Club Charities Trust; Caritas Medical Centre, Hong Kong

Completed

Be Healthy, So Easy: FAMILY Education Project

Hypokinesia

Hong Kong
IMAC Holdings, Inc.

Unknown

Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia

Bradykinesia

United States
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer (UroLymph)

Nocturia | Urogenital Cancer | Lower Limb Lymphedema | Nocturnal Polyuria

Belgium
Ankara Education and Research Hospital

Completed

Gated SPECT Abnormality With J Point Elevation

Myocardial Ischemia | Cardiovascular Diseases | Early Repolarization Syndrome | Electrocardiogram: Electrical Alternans | Left Ventricular Hypokinesia

Turkey
University of Aarhus
Ferring Pharmaceuticals

Completed

The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion

Nocturnal Enuresis | Nocturia | Gender Difference in V2 Receptor Function in Response to dDAVP Infusion

Denmark
Cliniques universitaires Saint-Luc- Université...

Unknown

NOCTURNAL PAIN After Knee Arthroplasty : Incidence and Risk Factor: an Observational Study (NOCTURN-PAIN)

Pain, Postoperative | Knee Osteoarthritis | Prosthesis (Internal) Complications | Nocturnal Frequency

Belgium
University Ghent

Completed

Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population

Monosymptomatic Nocturnal Enuresis

Belgium
University of Pittsburgh
National Institute on Aging (NIA)

Completed

Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production

Nocturnal Enuresis | Nocturia | Sleep Fragmentation | Poor Quality Sleep

United States
Shanghai Institute of Hypertension

Recruiting

Registry Study on "Control Nocturnal Hypertension to Reach the Target " (CONTROL-NHT)

Nocturnal Hypertension

China
University of Athens

Unknown

Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage

Nocturnal Hypertension

Greece
Gramercy Research Group

Active, not recruiting

Feasibility and Acceptability of an Online Program to Promote Physical Activity Among Black Women (LADIES Online)

Sedentary Behavior | Physical Inactivity | Lack of Physical Activity

United States
Inogen Inc.

Completed

Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia

Nocturnal Hypoxemia

United States
University Hospital, Ghent
Ferring Pharmaceuticals

Completed

Desmopressin Melt: Impact on Sleep and Daytime Functioning (SLEEP)

Monosymptomatic Nocturnal Enuresis

Belgium
High Point Pharmaceuticals, LLC.

Terminated

Safety Study of HPP593 in Subjects During and After Limb Immobilization

Muscle Atrophy | Hypodynamia

United States
Lancashire Teaching Hospitals NHS Foundation Trust
University of Central Lancashire

Completed

MyPad - Intelligent Bladder Pre-void Alerting System (MyPad)

Enuresis | Enuresis, Nocturnal

United Kingdom
Children's Hospital of Fudan University

Completed

Study on Chinese and Western Medicine in MNE Children

Monosymptomatic Nocturnal Enuresis

China
Cairo University

Unknown

Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis (PTNS)

Primary Monosymptomatic Nocturnal Enuresis

Egypt
UMC Utrecht

Terminated

Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients

Delirium

Netherlands
Ferring Pharmaceuticals

Completed

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PALAT)

Primary Nocturnal Enuresis

France
Kwang Dong Pharmaceutical co., ltd.

Recruiting

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

Hypoactive Sexual Desire Disorder

Korea, Republic of
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States
Warner Chilcott

Completed

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

Hypoactive Sexual Desire Disorder

United States
University of Wisconsin, Madison
Mayday Fund

Terminated

Vitamin D for Painful Nocturnal Leg Cramps

Leg Cramps, Nocturnal

United States
Gina Lockwood
PottyMD

Recruiting

Enuresis Alarm - Is a Manual Trigger System Beneficial?

Enuresis, Nocturnal

United States
Ferring Pharmaceuticals

Completed

Desmopressin Response in the Young (DRY)

Primary Nocturnal Enuresis

Canada
Seoul National University Hospital

Unknown

Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy

Prostatic Hyperplasia

Korea, Republic of
University of Johannesburg

Completed

The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause

Hypoactive Sexual Desire Disorder

South Africa
Emotional Brain NY Inc.

Completed

Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems

Hypoactive Sexual Desire Disorder

United States
Tel-Aviv Sourasky Medical Center

Unknown

Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder

Hypoactive Sexual Desire Disorder

Israel
University of Alabama at Birmingham

Completed

The Diurnal Rhythm in Natriuretic Peptide Levels

Obesity | Nocturnal Blood Pressure | Natriuretic Peptides

United States
Novartis Pharmaceuticals

Completed

Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria PNH

Lithuania, Japan, Czechia
Ra Pharmaceuticals

Completed

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, New Zealand, Korea, Republic of, Italy
AKARI Therapeutics

Completed

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576 (CAPSTONE)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Kazakhstan, Lithuania, Sri Lanka
Alexion Pharmaceuticals

Terminated

Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States, Czech Republic, Italy, Poland, United Kingdom
Seoul National University Hospital

Completed

Ability to Awaken in Nonmonosymptomatic Enuresis

Enuresis, Nocturnal, 2 (Disorder)
Alexion

Active, not recruiting

Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, Italy, Canada, Korea, Republic of, New Zealand, Spain, Turkey
Alexion

Completed

ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Belgium, France, Italy, Japan, Spain, Taiwan, United Kingdom, United States, Canada, Czechia, Germany, Sweden, Singapore, Korea, Republic of, Russian Federation, Austria, Poland, Argentina, Australia, Brazil, Estonia, Malaysia, Mexico, Thaila... and more
Apellis Pharmaceuticals, Inc.

Completed

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States

Clinical Trials on Nocturnal Hypokinesia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations